GSK Strikes $613M Deal With Omega For OTC Brands, Plant
British pharmaceutical giant GlaxoSmithKline PLC has agreed to sell six European over-the-counter drug brands and a manufacturing plant to Omega Pharma for €470 million ($613.6 million), in a continued effort to...To view the full article, register now.
Already a subscriber? Click here to view full article